The Center for Veterinary Medicine of the FDA has agreed to allow an important functionality claim for live yeast applied in ruminant feeding based on a research dossier of more than 39 published trials submitted by Lallemand Animal Nutrition. The claim allowed is, “to aid in maintaining cellulolytic bacteria population in the rumen of animals fed greater than 50% concentrate.” Continue Reading »
Lallemand-IFREMER partnership shows the benefits and possible modes of action of probiotic Bactocell in Summer Syndrome prevention in New Caledonian shrimp farms
Results of on-going Lallemand-IFREMER partnership on probiotic applications and mechanisms of actions in shrimp farming have been published in peer-reviewed journal Aquaculture1. Thanks to an original experimental system, the joint research program conducted by Mathieu Castex in Nouméa, New Caledonia (South Pacific), demonstrated that the administration of Bactocell® (Pediococcus acidilactici MA 18/5 M) in the feed of marine shrimps (Litopenaeus stylirostris) in farms usually affected by summer syndrome, could reduce vibriosis-associated mortality by up to 15%. As a result, final shrimp yield of the farm is increased.
We are proud to announce that Lallemand acquired Verdera Oy in the early days of February.
Verdera Oy is a Finnish company specializing in sustainable biological solutions for the forestry, horticulture and turf grass segments: they develop, manufacture and market bio-pesticides and growth stimulants for plant care uses. They export the products to more than 15 countries all over the world, primarily in Europe, North-America and Asia.
For more details, please visit their website: www.verdera.fi
March 2008
Lallemand SAS is a major supplier of yeast or bacteria and a primary producer of both. Core products are lyophilized bacteria for probiotics and silage inoculants, active dry yeast for probiotics and inactive yeast mineral supplements. The Animal Nutrition division is dedicated to the development, production, and marketing of a range of related animal health and nutrition products including yeast derivatives such as cell wall extracts used as prebiotics.
The company conducts its research and development through a combination of internal resources and external collaborations. The R&D department has the mission to generate scientific references on the product line efficacy, to develop new microbial solutions and collaborate tightly with the regulatory affairs team to build up registration dossiers.
To support the increasing regulatory and market needs, we are opening a new position for a:
R&D Manager Assistant
A new trial conducted by Milan University Department of Veterinary Science and Technologies for Food Safety highlights the benefits of Bactocell supplementation on laying hens zootechnical performance: egg yield and feed efficacy were increased. This new trial corroborates earlier work conducted on laying hens (Dr Awaad, Egypt 2005).
When Hy-line W36 hens were fed Bactocell (at 100 g/ton feed) during their whole laying cycle, overall egg yield was improved as compared to control diet: the hens laid more eggs (laying rate is increased by 2%), of bigger size (the proportion of L size eggs increased from 17.36% to 21.24%). At the same time, the amount of feed consumed did not change, resulting in better feed conversion rate thanks to the action of Bactocell in the gut. This aspect is particularly interesting as raw material prices puts extra pressure on farmers.
For more information about Milan University trial, please contact us
© 2008 Lallemand Animal Nutrition | Disclaimer | Lallemand inc
